BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:BAYN • DE000BAY0017

45.27 EUR
+0.27 (+0.59%)
Last: Feb 3, 2026, 05:36 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BAYN. BAYN was compared to 55 industry peers in the Pharmaceuticals industry. BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. BAYN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • BAYN had positive earnings in the past year.
  • BAYN had a positive operating cash flow in the past year.
  • In multiple years BAYN reported negative net income over the last 5 years.
  • Each year in the past 5 years BAYN had a positive operating cash flow.
BAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

  • BAYN has a worse Return On Assets (-0.19%) than 69.09% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.67%, BAYN is doing worse than 69.09% of the companies in the same industry.
  • BAYN has a Return On Invested Capital of 1.80%. This is in the lower half of the industry: BAYN underperforms 70.91% of its industry peers.
  • BAYN had an Average Return On Invested Capital over the past 3 years of 5.51%. This is significantly below the industry average of 14.23%.
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROIC 1.8%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
BAYN.DE Yearly ROA, ROE, ROICBAYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • The Operating Margin of BAYN (4.20%) is worse than 69.09% of its industry peers.
  • In the last couple of years the Operating Margin of BAYN has declined.
  • BAYN has a Gross Margin of 56.35%. This is in the lower half of the industry: BAYN underperforms 74.55% of its industry peers.
  • BAYN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.2%
PM (TTM) N/A
GM 56.35%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
BAYN.DE Yearly Profit, Operating, Gross MarginsBAYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BAYN is destroying value.
  • Compared to 1 year ago, BAYN has about the same amount of shares outstanding.
  • Compared to 5 years ago, BAYN has about the same amount of shares outstanding.
  • BAYN has a better debt/assets ratio than last year.
BAYN.DE Yearly Shares OutstandingBAYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
BAYN.DE Yearly Total Debt VS Total AssetsBAYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 1.02, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
  • BAYN has a Altman-Z score of 1.02. This is in the lower half of the industry: BAYN underperforms 72.73% of its industry peers.
  • BAYN has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as BAYN would need 10.07 years to pay back of all of its debts.
  • The Debt to FCF ratio of BAYN (10.07) is worse than 65.45% of its industry peers.
  • A Debt/Equity ratio of 1.11 is on the high side and indicates that BAYN has dependencies on debt financing.
  • The Debt to Equity ratio of BAYN (1.11) is worse than 67.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Altman-Z 1.02
ROIC/WACC0.26
WACC6.81%
BAYN.DE Yearly LT Debt VS Equity VS FCFBAYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that BAYN should not have too much problems paying its short term obligations.
  • BAYN has a worse Current ratio (1.14) than 67.27% of its industry peers.
  • BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.71, BAYN is not doing good in the industry: 74.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.71
BAYN.DE Yearly Current Assets VS Current LiabilitesBAYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

  • The earnings per share for BAYN have decreased by -8.72% in the last year.
  • Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
  • BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -1.87%.
  • Measured over the past years, BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.51% on average over the next years.
  • BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.22% yearly.
EPS Next Y-5.02%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
EPS Next 5Y3.51%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BAYN.DE Yearly Revenue VS EstimatesBAYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
BAYN.DE Yearly EPS VS EstimatesBAYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.48, which indicates a very decent valuation of BAYN.
  • Compared to the rest of the industry, the Price/Earnings ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 90.91% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.18, BAYN is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.27, the valuation of BAYN can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, BAYN is valued cheaper than 87.27% of the companies in the same industry.
  • BAYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.48
Fwd PE 9.27
BAYN.DE Price Earnings VS Forward Price EarningsBAYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAYN indicates a somewhat cheap valuation: BAYN is cheaper than 63.64% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BAYN is valued cheaper than 85.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.3
EV/EBITDA 12.25
BAYN.DE Per share dataBAYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.64%
EPS Next 3Y1.75%

More info and screens

0

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.25%, BAYN is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.95, BAYN is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.83, BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
BAYN.DE Yearly Dividends per shareBAYN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-65.15%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
BAYN.DE Yearly Income VS Free CF VS DividendBAYN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

FRA:BAYN (2/3/2026, 5:36:15 PM)

45.27

+0.27 (+0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)02-25
Inst Owners49.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap44.47B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts74.29
Price Target35.11 (-22.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)2.23%
PT rev (3m)20.79%
EPS NQ rev (1m)1.07%
EPS NQ rev (3m)-36.51%
EPS NY rev (1m)0.15%
EPS NY rev (3m)1.01%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)-1.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 8.48
Fwd PE 9.27
P/S 0.97
P/FCF 11.3
P/OCF 6.62
P/B 1.5
P/tB N/A
EV/EBITDA 12.25
EPS(TTM)5.34
EY11.8%
EPS(NY)4.89
Fwd EY10.79%
FCF(TTM)4.01
FCFY8.85%
OCF(TTM)6.84
OCFY15.12%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROCE 2.56%
ROIC 1.8%
ROICexc 2%
ROICexgc 6.8%
OM 4.2%
PM (TTM) N/A
GM 56.35%
FCFM 8.58%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Debt/EBITDA 5.32
Cap/Depr 66.1%
Cap/Sales 6.08%
Interest Coverage 1.09
Cash Conversion 109.39%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.71
Altman-Z 1.02
F-Score5
WACC6.81%
ROIC/WACC0.26
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.02%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
EPS Next 5Y3.51%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.28%
EBIT Next 3Y21.41%
EBIT Next 5Y12.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%

BAYER AG-REG / BAYN.DE FAQ

What is the fundamental rating for BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to BAYN.DE.


What is the valuation status of BAYER AG-REG (BAYN.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Fairly Valued.


How profitable is BAYER AG-REG (BAYN.DE) stock?

BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.


How financially healthy is BAYER AG-REG?

The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.


How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?

The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.